about
Tissue factor, protease activated receptors and pathologic heart remodellingRoles of PAR1 and PAR2 in viral myocarditis.Suppression of arterial thrombosis without affecting hemostatic parameters with a cell-penetrating PAR1 pepducin.Protease activated receptor-2 contributes to heart failure.Polymorphism in the protease-activated receptor-4 gene region associates with platelet activation and perioperative myocardial injury.Systems analysis of gene ontology and biological pathways involved in post-myocardial infarction responses.Effects of small platform catheter-based left ventricular assist device support on regional myocardial signal transduction.PAR-1 contributes to the innate immune response during viral infection.Coagulation, protease-activated receptors, and viral myocarditis.Multiple roles of the coagulation protease cascade during virus infection.Role of tissue factor in atherothrombosis.Mechanisms and consequences of inflammatory signaling in the myocardium.Pleiotropic effects of factor Xa and thrombin: what to expect from novel anticoagulants.Protease-Activated Receptor 1 Contributes to Angiotensin II-Induced Cardiovascular Remodeling and Inflammation.Identification of the first synthetic inhibitors of the type II transmembrane serine protease TMPRSS2 suitable for inhibition of influenza virus activation.Effect of PAR-2 Deficiency in Mice on KC Expression after Intratracheal LPS AdministrationUnexpected anti-hypertrophic responses to low-level stimulation of protease-activated receptors in adult rat cardiomyocytes.Lipopolysaccharide pretreatment increases protease-activated receptor-2 expression and monocyte chemoattractant protein-1 secretion in vascular endothelial cells.Hypercoagulability causes atrial fibrosis and promotes atrial fibrillation.
P2860
Q26824050-B783EFDE-C4E3-486E-8643-75880A7F1BD7Q33615082-812D24D1-E52E-455D-9814-9B8C2483E9A9Q34282119-240398AF-A90B-49E8-9015-3F8F30E7439DQ35060673-73CAB762-4D4E-4297-B1DF-41DE357FE43BQ35212303-7790FBE7-C12D-4ED6-A595-6E1EF048DA12Q35671282-D8323AA5-F4AF-4B8F-AA35-81ADE81EDAB6Q36260340-CE8F087E-3B94-4C80-93F4-10B37E129D55Q36638187-2566A0E5-8F9F-4A0E-BDF1-F107B08D7FD1Q37619823-CB46A1ED-8625-4673-90C3-2D79E97B8A58Q37723466-B6B96DA0-ACFA-4C4D-87CB-148DEB1393F9Q38034092-ADE5BA11-BDB1-402A-83A6-DF6F6D1D78C9Q38044254-97229431-6A29-4FC3-B168-BAB03FD2967AQ38175362-5032AF80-D2B3-4562-942C-EB48B0E10177Q39158447-C5A6B7C5-A9AE-4C4A-A8B5-D6ABBB97F009Q39175999-7201AA32-A997-4F18-9049-818E95D3499BQ39734752-C81C12FE-0CCA-488F-ADD4-9EC32602AC97Q42463329-B2D19EEB-D3A4-40F8-97B0-8D7F6EDAFD83Q47154353-A8B8988C-2EDD-4ECD-AD43-5E90AB5956E2Q53123644-55E976C4-ABBA-4ABA-8E30-AAB5386864AC
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Protease-activated receptors and myocardial infarction
@ast
Protease-activated receptors and myocardial infarction
@en
type
label
Protease-activated receptors and myocardial infarction
@ast
Protease-activated receptors and myocardial infarction
@en
prefLabel
Protease-activated receptors and myocardial infarction
@ast
Protease-activated receptors and myocardial infarction
@en
P2860
P356
P1433
P1476
Protease-activated receptors and myocardial infarction
@en
P2093
Rafal Pawlinski
Silvio Antoniak
P2860
P304
P356
10.1002/IUB.441
P577
2011-03-24T00:00:00Z